Byline Bancorp (NYSE:BY) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 5.8 percent decrease over earnings of $0.69 per share from the same period last year.
European Drug Regulator To Consider Expanded Use Of Novo Nordisk’s Wegovy Weight-Loss Drug
EMA's discussions on extending Novo Nordisk's Wegovy for reducing stroke and heart attack risks. SELECT trial results support its integration into public health systems.
